Table 2.
Summary of the properties of point-of-care rapid diagnostic testing for the COVID-19. Abbreviations: DOR (Diagnostics Odds-Ratio); NLR (Negative Likelihood Ratio); PLR (Positive Likelihood Ratio).
| Property | Value (95%CI) | Heterogeneity (p value) |
| Sensitivity (%) | 80.4% (53.9–90.1) | I2 = 79% (p < 0.001) |
| Specificity (%) | 97.7% (93.8–99.2) | I2 = 74% (p < 0.001) |
| NLR | 0.203 (0.094; 0.436) | I2 = 62% (p = 0.005) |
| PLR | 20.141 (8.207; 49.430) | I2 = 73% (p < 0.001) |
| DOR | 110.562 (32.720; 373.594) | I2 = 72% (p < 0.001) |
| Cohen’s Kappa | 0.75 (0.62; 0.88) | I2 = 96% (p < 0.001) |